Streetbeat News

Stock Prices

SBUX

Starbucks's (NYSE:SBUX) short percent of float has fallen 4.41% since its last report, with 14.60 million shares sold short, which is 1.3% of all regular shares available for trading. This decrease in short interest could signal a more bullish market sentiment towards Starbucks. Compared to its peers, Starbucks has less short interest as a percentage of float, with an average of 8.91%.

Portfolio Pulse from Benzinga Insights

July 19, 2023 | 4:30 pm

ODD

Oddity Tech, a newly listed company, has indicated an initial public offering (IPO) price of $48.67 per share on 549K shares, significantly higher than the IPO price of $35 per share.

Portfolio Pulse from Happy Mohamed

July 19, 2023 | 4:30 pm

AMZN

META

NVDA

QCOM

Nvidia Corp is in talks to take an equity stake in Lambda Labs, a startup that competes with Amazon Web Services and other cloud providers in renting servers with Nvidia chips. The deal could total $300 million in new capital and might value Lambda Labs at over $1 billion. BofA Global Research analyst Vivek Arya reiterated his Buy rating for Nvidia stock and raised his price target to $550 from $500. Qualcomm Inc tapped Meta Platforms Inc to optimize the execution of Meta's Llama 2 large language models on devices, which have primarily run on Nvidia graphics processors.

Portfolio Pulse from Anusuya Lahiri

July 19, 2023 | 4:23 pm

TPG

TPG Inc has agreed to acquire Nextech from Thomas H. Lee Partners for $1.4 billion. Nextech provides clinical and administrative healthcare technology solutions for specialty physician practices. The deal is expected to close in Q3 2023. This acquisition is part of TPG's focus on healthcare IT solutions. TPG's shares are trading higher by 0.45% at $31.09.

Portfolio Pulse from Lekha Gupta

July 19, 2023 | 4:21 pm

AAPL

Apple is reportedly developing its own generative AI tools, which has led to an increase in the company's stock price.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2023 | 4:19 pm

PBLA

Panbela Therapeutics Inc (NASDAQ:PBLA) has divested certain assets in its eflornithine pediatric neuroblastoma program to US WorldMeds 1 (USWM). Panbela is set to receive up to approximately $9.5 million in non-dilutive funding for the sale. Payments will be made upon USWM's successful completion of milestones related to eflornithine's clinical development, regulatory approval, and commercial sales. Following the news, PBLA shares rose by 24.90%.

Portfolio Pulse from Vandana Singh

July 19, 2023 | 4:18 pm

AMRN

AQMS

CVNA

HROW

MTB

PBLA

SEV

U.S. stocks traded higher with the Nasdaq Composite gaining around 0.5%. M&T Bank Corporation reported better-than-expected Q2 results with a revenue of $2.60 billion, beating the consensus of $2.39 billion. Harrow Health, Panbela Therapeutics, and Carvana Co. saw their shares rise after various positive announcements. However, Sono Group, Amarin Corporation, and Aqua Metals saw their shares drop due to negative news.

Portfolio Pulse from Lisa Levin

July 19, 2023 | 4:18 pm

HROW

NVS

Harrow Health Inc (HROW) has agreed to acquire the U.S. and Canadian commercial rights for Vevye, a drug for dry eye disease, from Novaliq GmbH. The company has also agreed to acquire certain U.S. and Canadian commercial rights for several branded products from Santen Pharmaceutical Co Ltd. In December last year, Harrow acquired exclusive U.S. commercial rights to five FDA-approved ophthalmic products from Novartis AG (NVS). Harrow raised $60 million via equity and expects Q2 2023 revenues in excess of $31.0 million. HROW shares are up 22.90%.

Portfolio Pulse from Vandana Singh

July 19, 2023 | 4:16 pm

PNFP

Pinnacle Financial Partners reported better-than-expected Q2 financial results, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2023 | 4:15 pm

DIS

Walt Disney Co (NYSE:DIS) CEO Bob Iger is facing criticism over his comments on the ongoing media industry strike over wages and working conditions. Iger, who recently extended his contract through 2026, called the strike disruptive and suggested that the strikers' expectations might not be realistic. His comments have been met with backlash, especially considering his own wealth and spending habits. Disney shares have fallen since Iger reassumed the CEO position, and the strike could further impact the company's financial future.

Portfolio Pulse from Chris Katje

July 19, 2023 | 4:13 pm